Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2022-10-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于董事局换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the re-election of the board of directors. It details the nomination and qualifications of candidates for the ninth board of directors, including both non-independent and independent directors. The document references compliance with company law, stock exchange rules, and company articles of association. It also includes biographical information about the candidates and confirms their qualifications and independence. There is no financial data, earnings information, or audit content. The document is clearly about changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 6449 characters, which is sufficient for a full announcement rather than a brief notice. Therefore, the correct classification is MANG with high confidence.
2022-10-14 Chinese
独立董事候选人声明（张华）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Shenzhen Haier Bioengineering Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There are no financial statements, earnings data, or management discussions. The content is focused on governance and compliance related to board membership qualifications. This type of document is typically classified under Board/Management Information (MANG) as it relates to announcements or declarations about board members or candidates.
2022-10-14 Chinese
独立董事候选人声明（王焕军）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Shenzhen Haier Bioengineering Co., Ltd. It details the candidate's qualifications, compliance with relevant laws and regulations, and independence criteria. The content is a statement related to board membership candidacy and does not contain financial data, audit information, or report publication. It is not an announcement of voting results or a proxy solicitation but a declaration related to board/management information. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (5600 characters) supports it being a full declaration rather than a brief announcement.
2022-10-14 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of supervisory board members (监事会换届选举) for Shenzhen Haiwang Bioengineering Co., Ltd. It details the nomination process, candidate qualifications, and upcoming shareholder meeting for approval. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the supervisory board, which is part of the company's governance and management structure. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a report announcement, so it is not RPA or 10-K. Hence, the classification is MANG with high confidence.
2022-10-14 Chinese
第八届监事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting date, voting results, and mentions that certain proposals will be submitted to the shareholders' meeting. The content focuses on board/committee decisions and internal governance matters, specifically about the supervisory board election and remuneration. There is no financial data, no mention of annual or quarterly reports, no earnings information, and no regulatory filings or certifications. The document is not a report itself but an announcement of board/management decisions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management decisions, supporting this classification with high confidence.
2022-10-14 Chinese
第八届董事局第二十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Shenzhen Haier Bioengineering Co., Ltd. It details the convening of the board meeting, voting results on various board-related proposals including election of directors and director remuneration, and references further announcements to be made to shareholders. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is clearly an announcement of board/management changes and related decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2022-10-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.